OVID

Ovid Therapeutics Inc.

NasdaqCM · Healthcare

$2.60

-3.85% today

last filing 2026-07-06Pro sees filings in ~15 min

Price

hover · 4 moves explained

2 sells

Analyst consensus

$5.47target+110.4%vs $2.60 today

$4.00 low today target$7.00 high

9 analysts · ~12-month consensus · as of Jul 10. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25+59.3%

−$0.06

exp −$0.15

Q3 '25-14.9%

−$0.17

exp −$0.15

Q4 '25

$0.06

exp −$0.10

Q1 '26-13.2%

−$0.12

exp −$0.11

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-07-08	Carter Charles Ross	Chief Financial Officer	—Direct	50,000	—	—
Grant	2026-03-02	Rona Jeffrey A	CBFO	—Direct	68,125	—	—
Sell	2026-03-02	Rona Jeffrey A	CBFO	—Direct	8,541	$1.45	$12.4K
Sell	2026-03-02	ALEXANDER MARGARET A.	President and CEO	—Direct	11,656	$1.45	$16.9K
Convert	2025-12-18	LEVIN JEREMY M	CEO	—Direct	71,000	—	—

Grant

Carter Charles Ross

Chief Financial Officer · 2026-07-08

—

50,000 shares

Grant

Rona Jeffrey A

CBFO · 2026-03-02

—

68,125 shares

Sell

Rona Jeffrey A

CBFO · 2026-03-02

$12.4K

8,541 @ $1.45

Sell

ALEXANDER MARGARET A.

President and CEO · 2026-03-02

$16.9K

11,656 @ $1.45

Convert

LEVIN JEREMY M

CEO · 2025-12-18

—

71,000 shares

1 more transaction on ProFull insider transaction history is a Pro feature.

Upgrade →